Global Blood Plasma Market: Trends, Opportunities and Forecasts (2015-2020) - (By Market Segment, Type of Blood Plasma -IVIG, Albumin, Factor VIII, By Region-North America, Europe, APAC, Market Entry Strategies for Global Players)


#505884

155pages

Azoth Analytics

$ 2200

In Stock

The market is driven by the consumer awareness of health care resulting in access for treatment along with increase in the global ageing populace which faces these kind of health problems at that age.

Table of Contents

1. Research Methodology  

2. Product Overview  

3. Executive Summary  

4. Global Blood Plasma Market: An Analysis  
4.1. Global Blood Plasma Market: Size, Growth and Forecast 
4.1.1. By Value & Forecast
4.2. Global Blood Plasma Market: Segment Shares & Analysis 
4.2.1. By Product Type
4.2.2. By Company
4.3. Global Albumin Type Blood Plasma Market: Size, Growth and Forecast
4.3.1. By Volume
4.3.2. By Value
4.3.3 By Company
4.4. Global IVIG Type Blood Plasma Market: Size, Growth and Forecast
4.4.1. By Value
4.4.2 By Volume
4.5. Global Factor VIII Type Blood Plasma Market: Size, Growth and Forecast
4.5.1 Overview
4.5.2 By Value
4.5.3 By Volume
4.6. Other Blood Products Market: Size, Growth and Forecast
4.6.1. By Value (Forecast 2020F)

5. North America Blood Plasma Market: Size, Growth and Forecast  
5.1. Overview 
5.2. By Value (Forecast 2015E-2020F) 
5.3. Factors Affecting Market

6. APAC Blood Plasma Market: Size, Growth and Forecast  
6.1. Overview 
6.2. By Value (Forecast 2015E-2020F) 
6.3. Factors Affecting Market

7. Europe Blood Plasma Market: Size, Growth and Forecast
7.1. By Value (Forecast 2015E-2020F)

8. RoW Blood Plasma Market: Size, Growth and Forecast   
8.1. Overview 
8.2. By Value (Forecast 2015E-2020F) 
8.3. Factors Affecting Market

9. Blood Plasma Market Trends  
9.1.Overview 
9.1.1. Solid and Stable Pricing Power in IG Market
9.1.2. Fast Growth of SCIG Market
9.1.3. Industrial Fractionators Planning Capacity Expansion
9.1.4. Increase in Albumin Market in China
9.1.5. Immunoglobulin Segment- High Profitability and Strength

10. Global Blood Plasma Market Dynamics  
10.1. Growth Drivers 
10.1.1. Augmentation in Plasma accumulations in the US
10.1.2. Rise in Global Healthcare Expenditure
10.1.3. Growth in Ageing Population
10.1.4. Growth in Male Population
10.1.5. Development Potential from New Indications
10.2. Challenges 
10.2.1. Rivalry from Recombinant Factor VIII
10.2.2. Prospective Threat to Immunoglobulin Market
10.2.3. Costing Pressure in Tenders in Plasma-Derived FVIII Market
10.2.4. High Manufacturing and Safety Cost

11. Blood Plasma Market: Policy and Regulatory Landscape  
11.1. WHO Blood Safety Regulations 
11.2. FDA Blood Safety Regulations 
11.3. CANADA    CAN/CSA-Z902-10 (R2015) - Blood and blood components 
11.4. PHARMACEUTICAL AND FOOD SAFETY BUREAU (PFSB) JAPAN 
11.5. UK Blood Safety Regulations 
11.6. Australia Blood Safety Regulations 
11.7. India Plasma Product Safety Regulations

12. Blood Plasma Market: Value Chain Analysis  
12.1. Supply Chain Diagram 
12.2. BLOOD PLASMA SUPPLY CHAIN

13.  Blood Plasma Trade Data Analysis  
13.1. Top 5 Nations with Import By Volume (Million KGS) 
13.2. Top 5 Nations with Export By Volume (Million KGS) 
13.3. Top 5 Nations with Import by Value (Billion $) 
13.4. Top 5 Nations with Export by Value (Billion $)

14. Blood Plasma Market: Porter’s Five Force Analysis  
14.1. Porter Five Force Model Blood Plasma

15. Blood Plasma Market: Competitive landscape  
15.1. Blood Plasma Market: Company Financials 
15.1.1. Top 5 Companies Sales
15.1.2. Bottom 5 Companies Sales
15.1.3. Top 5 Companies EBITDA
15.1.4. Bottom 5 Companies EBITDA
15.1.5. Top 5 Companies EBIT
15.1.6. Bottom 5 Companies EBIT
15.1.7. Top 5 Companies PBT
15.1.8. Bottom 5 Companies PBT
15.1.9. Top 5 Companies PAT
15.1.10. Bottom 5 Companies PAT
15.2 Company Ratios 
15.2.1. Top 5 Companies Current Ratio
15.2.2. Bottom 5 Companies Current Ratio
15.2.3. Top 5 Companies Profit Margin
15.2.4. Bottom 5 Companies Profit Margin
15.2.5. Top 5 Companies Debt Equity Ratio

16. Global Blood Plasma Market: Company Profiles  
16.1. CSL Ltd. 
16.2 Baxter International Inc  
16.3 Grifols S.A 
16.4 Antares Pharma Inc 
16.5 Emergent BioSolutions, Inc. 
16.6 AMAG Pharmaceuticals, Inc. 
16.7 Cipla 
16.8 Octopharma 
16.9 Biota Pharmaceuticals, Inc. 
16.10 BioDelivery Sciences International, Inc.

17.  Strategic Recommendations  

Figure 1: Global Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Figure 2: Growth in Global Ageing Population (2010-2014) in Million
Figure 3: Global Blood Plasma Market Size, By Value, 2015E-2020F (USD Billion)
Figure 4: Global Per Capita Health care Expenditure (USD)
Figure 5: Blood plasma Market Share, By Product 2014
Figure 6: Blood Plasma Market Share, By Product, By Value, 2014(USD Billion)
Figure 7: Blood plasma Market, By Company Share 2014 (Percentage)
Figure 8: Blood Plasma Market, Company Share, By Value, 2014(USD Billion)
Figure 9: Blood plasma Market Immunoglobulin By Company 2014
Figure 10: Blood plasma Market Factor VIII By Company 2014
Figure 11: Global Albumin Market Size, By Volume, 2010-2014 (tons)
Figure 12: Global Albumin Market Size, By Volume, 2015E-2020E (tons)
Figure 13: Global Albumin Market Size, By Value, 2010-2014 (USD Billion)
Figure 14: Global Albumin Market Size, By Value, 2015E-2020E (USD Billion)
Figure 15: Blood plasma Market Albumin By Company 2014
Figure 16: Global IVIG Market Size, By Volume, 2010-2014 (tons)
Figure 17: Global IVIG Market Size, By Volume, 2015E-2020E (tons)
Figure 18: Global IVIG Market Size, By Value, 2010-2014 (USD Billion)
Figure 19: Global IVIG Market Size, By Value, 2015E-2020E (USD Billion)
Figure 20: Global Factor VIII Market Size, By Value, 2010-2014 (USD Billion)
Figure 21: Global Factor VIII Market Size, By Value, 2015E-2020E (USD Billion)
Figure 22: Global Factor VIII Market Size, By Volume, 2010-2014 (International Units)
Figure 23: Global Factor VIII Market Size, By Volume, 2015E-2020E (International Units)
Figure 24: Other Blood Products Market Size, By Value, 2010-2014 (USD Billion)
Figure 25: Other Blood Products Market Size, By Value, 2015E-2020E (USD Billion)
Figure 26: North America Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Figure 27: North America Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
Figure 28: North America Aging Population, 2010-2020 (Million)
Figure 29: North America Blood Plasma Export to China, By Value, 2010-2014 (USD Billion)
Figure 30: Plasma Collection In America, By Volume, 2010-2014 (Million Litres)
Figure 31: APAC Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Figure 32: APAC Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
Figure 33: China Blood Plasma Import from North America, By Value, 2010-2014   (USD Million)
Figure 34: Europe Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Figure 35: Europe Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
Figure 36: ROW Blood Plasma Market Size, By Value, 2010-2014 (USD Billion)
Figure 37: ROW Blood Plasma Market Size, By Value, 2015E-2020E (USD Billion)
Figure 38: IVIG (KG/M) Usage Comparison
Figure 39: US Plasma Accumulations (2010-2014)
Figure 40: Rise in Global Healthcare Expenditure, 2010-2014 USD
Figure 41: Growth in Global Ageing Population (2010-2014) Million
Figure 42: Growth in Male Population, 2010-2014 (Million)
Figure 43:  Blood Plasma Imports, By Top Countries, 2010-2014 (Million KGS)
Figure 44: Blood Plasma Exports, By Top Countries, 2010-2014 (Million KGS)
Figure 45: Blood Plasma Imports, By Top Countries, 2010-2014 (Billion $)
Figure 46: Blood Plasma Exports, By Top Countries, 2010-2014 (Billion $)
Figure 47: Top 5 Companies Sales in USD Billion
Figure 48: Bottom 5 Companies Sales in USD Million
Figure 49: Top 5 Companies EBITDA in USD Billion
Figure 50: Bottom 5 Companies EBITDA in USD Billion
Figure 51: Top 5 Companies EBIT in USD Billion
Figure 52: Bottom 5 Companies EBIT in USD Billion
Figure 53: Top 5 Companies PBT in USD Billion
Figure 54: Bottom 5 Companies PBT in USD Billion
Figure 55: Top 5 Companies PAT in USD Billion
Figure 56: Bottom 5 Companies PAT in USD Billion
Figure 57: Top 5 Companies Current Ratio
Figure 58: Bottom 5 Companies Current Ratio
Figure 59: Top 5 Companies Profit Margin
Figure 60: Bottom 5 Companies Profit Margin
Figure 61: Top 5 Companies Debt Equity Ratio
Figure 62: CSL Ltd. Percentage Revenue, By Product Segment (2014-2015)
Figure 63:  CSL Ltd. Percentage Revenue, By Geography (2014-2015)
Figure 64: CSL Ltd. Sales (USD Billion) 2010-2014
Figure 65: Baxter International Inc. Percentage Revenue, By Product Segment (2014)
Figure 66: Baxter International Inc. Percentage Revenue, By Geography (2014)
Figure 67: Baxter International Inc.  Sales (USD Billion) 2010-2014
Figure 68: Grifols S.A Percentage Revenue, By Product Segment (2014)
Figure 69: Grifols S.A Percentage Revenue, By Geography (2014)
Figure 70: Grifols SA Sales (USD Billion) 2010-2014
Figure 71: Antares Pharma Inc. Revenue (USD Billion) 2010-2014
Figure 72: Emergent BioSolutions, Inc. Revenue (USD Billion) 2010-2014
Figure 73: AMAG Pharmaceuticals, Inc. Revenue (USD Billion) 2010-2014
Figure 74: Octopharma Revenue (USD Billion) 2010-2014
Figure 75: Biota Pharmaceuticals, Inc. Revenue (USD Billion) 2010-2014
Figure 76: BioDelivery Sciences International, Inc. Revenue (USD Billion) 2010-2014
Figure 77: Flamel Technologies SA. Revenue (USD Billion) 2010-2014